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Introduction
Cf-252 neutron brachytherapy is
advantgeous to use for treatment of radioresistant
tumors.
Material and methods
45 pts. (I) with cervix carcinoma received
combined radiation therapy: external Co-60
gamma therapy (37.3 Gy) for pelvis and HDR Cf-
252 brachytherapy (point A-35.4 Gy-eq).
Results
The treatment results were compared
with historical similar group - 64 pts (II) treated
by external Co-60 gamma therapy (39.7 Gy) and
OPTIMISATION IN HDR BRACHYTHERAPY
HDR Co-60 brachytherapy (point A-47.4 Gy).
There were no significant difference in 4 year
survival: 73.3% (I) vs 79.7% (II). Local failure was
observed in 22.2% (I) and 10.9% (II) cases. The
rate of late radiation complications was simiral -
4.4% (I) vs 1.6% (II). Acute reactions were
brachytherapy dose dependent with ED50:80.1
Gy-eq and 74.5 Gy in I and II groups respectively.
Conclusions
Radiobiological analysis of obtained data
show some possibilities to improve treatment
results in HDR Cf-252 brachytherapy group.
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New HDR machines supplied with stepping
source systems give us an additional opportunity
to optimise source distribution by modeling source
dwell time. Different optimization algorithms
are implemented in the commercial planning
systems connected with HDR machines. The choice
of proper optimization procedures is basic
for Quality Assurance in brachytherapy planning.
The main ideas of optimization algorithms
implemented in PLATO system are presented.
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Some examples of gynaecological,
intralumenal and interstitial brachytherapy are
analyzed. Nonoptimised and "geometrically"
optimized interstitial implants are compared. The
advantages of optimization are discussed on the
basic of dose-volume histograms. The danger of
wrong optimization is also discussed.
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